RxDoctor Payments Data

Nancy Mattoni

Nurse Practitioner · Rochester Hills, MINPI 1316020902

Payments from drug & device makers

$1,183in general payments, 2019–2025

Across 58 payments — averaging $20.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astellas Pharma US Inc$289
  • Pfizer$166
  • Exact Sciences$157
  • Amgen$126
  • Novo Nordisk$101
  • Otsuka America Pharmaceutical, Inc.$61
  • plus $284 from 12 others

What the payments were for

  • Food & beverage$1,11895%
  • Education$655%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,183 in reported general payments places this provider in the 80th percentile of 3,351 nurse practitioner providers in Michigan.

See all nurse practitioner providers in Michigan

Medicare billing

Part B allowed, 2024
$16,582
Medicare patients
163
Services billed
317

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol168$6,334
PremarinEstrogens, Conjugated16$4,540
DottiEstradiol17$2,882
Estradiol (Twice Weekly)Estradiol18$1,881
ProgesteroneProgesterone, Micronized36$1,497
YuvafemEstradiol20$1,319
Alendronate Sodium76$738
Albuterol Sulfate HfaAlbuterol Sulfate16$480
Clobetasol Propionate13$466
Levothyroxine Sodium32$367
Medroxyprogesterone Acetate14$322
Atorvastatin Calcium28$271
Escitalopram Oxalate21$265
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip21$258
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst24$182

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerPremarin$166$4,54016 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,351 nurse practitioner providers in Michigan.

Other nurse practitioner in Rochester Hills

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →